Aug 16, 2025 at 5:24 PM#6
100%. My provider said the same thing about Eli Lilly patient.
Last edited: Aug 16, 2025 at 9:24 PM
10 19wanda_boise, NurseAsh_DET, BenResearch_OR and 7 others
Reply Quote Save Share Report
Aug 16, 2025 at 5:41 PM#7
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Eli Lilly patient.
To answer Dr.NateNeph: my doctor and I discussed the options and went with brand.
Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Last edited: Aug 16, 2025 at 10:41 PM
17 18HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 14 others
Reply Quote Save Share Report
Aug 16, 2025 at 5:58 PM#8
Adding my data to this Eli Lilly patient discussion:
| Metric | Baseline | Month 3 | Month 6 |
|---|---|---|---|
| Weight | 276 lbs | 231 lbs | 201 lbs |
| A1C | 7.0% | 5.8% | 5.2% |
| hsCRP | 5.0 | 2.0 | 1.0 |
Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.
49 14Dr.PulmRoch, maya_sedona, stefan_berlin and 46 others
Reply Quote Save Share Report
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsAug 16, 2025 at 6:15 PM#9
+1 to pam_stl. Especially the point about "Thank you all for the thoughtful replies..." — I have seen the same in my own experience with Eli Lilly patient.
Last edited: Aug 16, 2025 at 11:15 PM
38 10SkepticalSean, Dr.CardioMD, EndoResFellow and 35 others
Reply Quote Save Share Report
Aug 16, 2025 at 6:32 PM#10
Slightly tangential to Eli Lilly patient but james_edin reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
15 21LibrarianMeg, bri_stats, pete_manc_UK and 12 others
Reply Quote Save Share Report